Guest writer Shara Sand says that her severe mood changes went unidentified until a psychiatrist diagnosed her with bipolar ...

Tyruko, the first biosimilar of Tysabri, is now available in the U.S., providing a lower-cost treatment option for adults ...

A clinical trial testing an experimental vaccine for the Epstein-Barr virus (EBV) in people with MS is now recruiting ...

Vision changes with SPMS can involve slow visual processing and motion sensitivity, but it’s possible to manage them.

Shara Sand is a practicing psychologist and retired associate professor. She specializes in gender, sexuality, and disability issues and works with creative and performing artists. Shara identifies as ...

Understanding changes, seeking support, and staying connected can help caregivers adapt to the challenges of secondary progressive MS.

MS and MOGAD share similar symptoms but are two biologically distinct conditions, with different immune signatures, a study ...

Maybe healing after an MS relapse isn't in striving to feel better, but is found in savoring where you are now, writes ...

Mesenchymal stem cell therapy shows promise for treating MS, but more research is needed on long-term safety and efficacy, a ...

As Thanksgiving approaches, columnist Leigh Anne Nelson is focused on what gratitude really means and appreciating the small ...

Two Phase 3 trials testing the investigational oral therapy fenebrutinib in people with multiple sclerosis (MS) have hit ...

The ComSLI method uses simple tools to generate detailed images of brain nerve fibers and damage in neurological diseases, ...